Skip to content

Clinical trials

Phase 1/2 Colorectal Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colorectal Neoplasms Phase: Phase 1/2 Country / region: Japan Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20061
20072
20082
20121
20151
20161
20191
20201
20213
20231
20244
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Active, not recruiting6
Completed6
Terminated3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
Novartis Pharmaceuticals3
AstraZeneca2
Eisai Inc.2
Tokyo University2
BioNTech SE1
Boehringer Ingelheim1
Chugai Pharmaceutical1
Daiichi Sankyo1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colorectal Neoplasms23
Endometrial Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Biliary Tract Neoplasms4
Colonic Neoplasms4
Neoplasms4
Rectal Neoplasms4
Carcinoma, Hepatocellular3
Neoplasm Metastasis3
Ovarian Neoplasms3

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.